Laurus Labs acquires a small stake in cell and gene therapy company - ImmunoACT
Laurus Labs acquires a small stake in cell and gene therapy company - ImmunoACT

Laurus Labs acquires a small stake in cell and gene therapy company - ImmunoACT

In India, CAR-T therapy is not available and this collaboration will help them in bringing this novel technology to Indian patients at very affordable pricing.

DSIJ Intelligence Article rating: 3.7

Laurus Labs has signed an investment agreement with Immunoadoptive Cell Therapy Private Limited (ImmunoACT), an advanced cell and gene therapy company to acquire a 26.62 per cent stake (fully diluted basis) for a cash consideration of approximately Rs 46 crore, subject to the fulfilment of certain conditions. 

Stock watch: Is BSE Limited all set to zoom?
Stock watch: Is BSE Limited all set to zoom?

Stock watch: Is BSE Limited all set to zoom?

Post consolidating for 16 weeks in an ascending triangle chart pattern, BSE Limited on weekly charts gave breakout with increased volumes. Read on to find out more.

DSIJ Intelligence Article rating: 4.0

Post consolidating for 16 weeks in an ascending triangle chart pattern, BSE Limited on weekly charts gave breakout with increased volumes. Read on to find out more.

Ten stocks close to their 52-week high
Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

The 52-week high refers to the highest market price of a given security over a 52-week (one year) period.

Avalokita Pandey Article rating: 3.8

Here’s a list of the stocks that are close to their 52-week high.

Five stocks witnessing short covering
Five stocks witnessing short covering

Five stocks witnessing short covering

Short covering refers to buying back borrowed securities in order to close out an open short position at a profit or loss.

Avalokita Pandey Article rating: 3.3

List of the stocks where sell positions are being covered in the F&O segment.

Five stocks witnessing long unwinding
Five stocks witnessing long unwinding

Five stocks witnessing long unwinding

Long unwinding refers to selling of positions or stocks owned for a longer period either to book profit or to exit it in anticipation of impending bearishness.

Avalokita Pandey Article rating: 3.0

Following are the stocks where profit booking is seen taking place in the F&O segment.

After a miserable debut on stock exchanges, will October 2021 business update propel the stock of Paytm?
After a miserable debut on stock exchanges, will October 2021 business update propel the stock of Paytm?

After a miserable debut on stock exchanges, will October 2021 business update propel the stock of Paytm?

The growth momentum in gross merchandise value (GMV) continued in October 2021, driven by festive season spending as well as an increase in the number of merchants & consumers

DSIJ Intelligence-3 Article rating: 4.0

The lending business continued to show very strong growth as a result of the rapid scale-up of all of company’s lending products, including postpaid, consumer loans, and merchant loans.

RSS
First22312232223322342236223822392240Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

SEBI Registered Research Analyst Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INH000006396
Validity: Oct 05, 2018 - Perpetual
BSE Enlistment No. 5307

SEBI Registered Investment Adviser Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INA000001142
Validity: Aug 19, 2019 - Perpetual
BSE Enlistment No. 1346

Registered and Correspondence Office Address :
DSIJ PVT LTD. Office No - 409,
Solitaire Business Hub, Kalyani Nagar, Pune - 411006
Tel: +91 022-43476012/13/14/15 | Email: service@dsij.in
CIN No.: U22120MH2003PTC139276
GST No.: 27AACCR4303G1ZP

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR

Disclaimer: "Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors"

Investment in securities market is subject to market risks. Read all the related documents carefully before investing.

Any act of copying, reproducing, or distributing the content whether wholly or in part, for any purpose without the permission of DSIJ is strictly prohibited and shall be deemed to be copyright infringement.

Disclosures | Terms & Conditions | Privacy Statement | WhiteList